SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-115663
Filing Date
2014-03-26
Accepted
2014-03-26 08:45:57
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d667938d10k.htm 10-K 1539849
2 EX-3.2 d667938dex32.htm EX-3.2 96051
3 EX-21.1 d667938dex211.htm EX-21.1 2022
4 EX-23.1 d667938dex231.htm EX-23.1 1437
5 EX-31.1 d667938dex311.htm EX-31.1 8923
6 EX-31.2 d667938dex312.htm EX-31.2 8970
7 EX-32.1 d667938dex321.htm EX-32.1 6046
  Complete submission text file 0001193125-14-115663.txt   8816268

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT mstx-20131231.xml EX-101.INS 966661
9 XBRL TAXONOMY EXTENSION SCHEMA mstx-20131231.xsd EX-101.SCH 82420
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mstx-20131231_cal.xml EX-101.CAL 86584
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mstx-20131231_def.xml EX-101.DEF 192158
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE mstx-20131231_lab.xml EX-101.LAB 596076
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mstx-20131231_pre.xml EX-101.PRE 378556
Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32157 | Film No.: 14717498
SIC: 2834 Pharmaceutical Preparations